AW Kurian, EE Hare, MA Mills, KE Kingham… - Journal of clinical …, 2014 - ascopubs.org
Purpose Multiple-gene sequencing is entering practice, but its clinical value is unknown. We evaluated the performance of a customized germline-DNA sequencing panel for cancer-risk …
F Wang, L He, P Huangyang, J Liang, W Si, R Yan… - PLoS …, 2014 - journals.plos.org
Jumonji domain-containing 6 (JMJD6) is a member of the Jumonji C domain-containing family of proteins. Compared to other members of the family, the cellular activity of JMJD6 is …
YF Lee, LD Miller, XB Chan, MA Black, B Pang… - Breast Cancer …, 2012 - Springer
Introduction We developed an analytic strategy that correlates gene expression and clinical outcomes as a means to identify novel candidate oncogenes operative in breast cancer …
V Bhatia, A Yadav, R Tiwari, S Nigam, S Goel… - Clinical Cancer …, 2019 - AACR
Abstract Purpose: Serine peptidase inhibitor, Kazal type-1 (SPINK1) overexpression defines the second most recurrent and aggressive prostate cancer subtype. However, the underlying …
JY Li, R Jing, H Wei, M Wang, Q Xiaowei… - … journal of cancer, 2019 - Wiley Online Library
Multigene panel testing of breast cancer predisposition genes have been extensively conducted in Europe and America, which is relatively rare in Asia however. In this study, we …
T Suwa, M Kobayashi, Y Shirai, JM Nam, Y Tabuchi… - JCI insight, 2021 - ncbi.nlm.nih.gov
Hypoxia is associated with tumor radioresistance; therefore, a predictive marker for tumor hypoxia and a rational target to overcome it have been sought to realize personalized …
R Rangel, SC Lee, K Hon-Kim Ban… - Proceedings of the …, 2016 - National Acad Sciences
Triple-negative breast cancer (TNBC) has the worst prognosis of any breast cancer subtype. To better understand the genetic forces driving TNBC, we performed a transposon …